Job Research Foundation seeks to find a cure for Job Syndrome and provide support for research into treatments.
The Job Research Foundation supports research into a cure and treatment for those suffering from Job Syndrome, a rare multisystem immunodeficiency disorder.
NEW YORK (PRWEB)
April 09, 2020
The Job Research Foundation has announced the recipients of its second round of grant funding that will support investigation into the causes of and treatments for Job Syndrome. The Foundation awarded four two-year grants of $200,000 each to support four research projects. The recipients are:
Andrew Gennery, MD, Professor in Paediatric Immunology and Haematopoietic Stem Cell Therapies
University of Newcastle upon Tyne/Great North Children’s Hospital
Title: Investigating Health Status and Quality of Life in Patients with Autosomal Dominant Hyper IgE Syndrome
Vera P. Krymskaya, PhD, MBA, FCPP, Professor of Medicine
University of Pennsylvania
Title: Nanotechnology as a Novel Cellular Therapy for Patients with Job Syndrome
Hongmei Mou, PhD, Assistant Professor
Massachusetts General Hospital/Harvard Medical School
Title: Impaired Epithelial Differentiation and Host Defense as a Mechanism for Pulmonary Complications in Job Syndrome Patients
Scott B. Snapper, MD, PhD, Wolpow Family Chair & Director, IBD Center; Professor of Pediatrics, HMS
Boston Children’s Hospital/Harvard Medical School
Title: Investigating a Non-Transcriptional Role for Il-10-STAT3 in Mitochondrial Metabolism and AD-HIES
The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome.
Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit http://www.jobresearchfoundation.org for additional details.
# # #
Share article on social media or email: